LCUK:F:F-Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist (EUR)

ETF | Others |

Last Closing

USD 13.12

Change

+0.16 (+1.23)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+7.00 (+1.39%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.97 (+2.08%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.27 (+2.49%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.31 (+2.24%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+0.89 (+0.99%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.40 (+1.61%)

USD 45.80B
0ZC:F Zscaler Inc

+5.80 (+3.32%)

USD 37.92B
BSND:F Danone SA

+0.30 (+2.14%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+1.46 (+1.27%)

USD 24.77B

ETFs Containing LCUK:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.95% 59% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.95% 59% D- 63% D
Trailing 12 Months  
Capital Gain 1.41% 68% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.41% 64% D 56% F
Trailing 5 Years  
Capital Gain 41.78% 50% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.78% 50% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain 8.71% 64% D 62% D
Dividend Return 8.71% 61% D- 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.49% 64% D 90% A-
Risk Adjusted Return 83.02% 81% B- 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike